Similar articles

• The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.

  Lin PC, Chang CH, Hsu PI, Tseng PL, Huang YB. Lin PC, et al. Crit Care Med. 2010 Apr;38(4):1197-205. doi: 10.1097/CCM.0b013e3181d69ccf. Crit Care Med. 2010. PMID: 20173630
• A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.

  Young PJ, Bagshaw SM, Forbes A, Nichol A, Wright SE, Bellomo R, Bailey MJ, Beasley RW, Eastwood GM, Festa M, Gattas D, van Haren F, Litton E, Mouncey PR, Navarra L, Pilcher D, Mackle DM, McArthur CJ, McGuinness SP, Saxena MK, Webb S, Rowan KM; Australian and New Zealand Intensive Care Society Clinical Trials Group on behalf of the PEPTIC investigators. Young PJ, et al. Crit Care Resusc. 2018 Sep;20(3):182-189. Crit Care Resusc. 2018. PMID: 30153780 Clinical Trial.
• Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.

  Toews I, George AT, Peter JV, Kirubakaran R, Fontes LES, Ezekiel JPB, Meerpohl JJ. Toews I, et al. Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD008687. doi: 10.1002/14651858.CD008687.pub2. Cochrane Database Syst Rev. 2018. PMID: 29862492 Free PMC article. Review.
• Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.

  Faleck DM, Salmasian H, Furuya EY, Larson EL, Abrams JA, Freedberg DE. Faleck DM, et al. Am J Gastroenterol. 2016 Nov;111(11):1641-1648. doi: 10.1038/ajg.2016.343. Epub 2016 Aug 30. Am J Gastroenterol. 2016. PMID: 27575714 Free PMC article.
• What's new with stress ulcer prophylaxis in the ICU?

  Marker S, Krag M, Møller MH. Marker S, et al. Intensive Care Med. 2017 Aug;43(8):1132-1134. doi: 10.1007/s00134-017-4733-0. Epub 2017 Feb 25. Intensive Care Med. 2017. PMID: 28238056 Review. No abstract available.